Willow stops selling oral GLP-1 drops after it is sued by pharmaceutical manufacturer Eli Lilly for false advertising Willow previously sold GLP-1 oral drops, but stopped selling them after pharmaceutical manufacturer Eli Lilly sued Willow for false advertising
A new study, Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide , has raised concerns that these widely used medications may be linked to an increased risk of certain vision-threatening conditions
Are you concerned about using needles but need to control your diabetes and lose weight
Corresponding author: Mi Jin Moon
Researchers have explored similar multi-peptide combinations in experimental models relating to cellular regulation, peptide-mediated signalling behaviour, and broader biochemical processes under controlled laboratory conditions
Time-to-event analyses were performed using KaplanMeier curves with log-rank tests and Cox proportional hazards models to estimate hazard ratios and 95% confidence intervals, accounting for variable follow-up and censoring
